Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 15, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 17, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000816956-26-000096
Filed / recorded
Jul 17, 2026, 7:09 PM UTC
Added to OQRO
Oct 6, 2026, 10:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CONMED Corp
Issuer CIK
816956
Ticker
CNMD
Reporting person
John E Gallagher
Relationship
Officer
Officer title
Executive Vice President & CFO
Security
Options To Purchase Common Stock
Table
Derivative (Table II)
Transaction date
Jul 15, 2026
Transaction code
A
Shares / units
30,536
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
30,536
Ownership form
Direct
Amendment
No
Footnotes from the filing
The stock options were granted under CONMED Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.